Immunological disorders and DNA repair

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 509, Issue 1-2, 2002, Pages 109-126

  O'Driscoll, Mark ^a   Jeggo, Penny ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

Author keywords

Double strand break repair; Immunodeficiency; Radiosensitivity; V(D)J recombination

Indexed keywords

8 HYDROXYGUANINE; CATALASE; COPPER ZINC SUPEROXIDE DISMUTASE; DNA (APURINIC OR APYRIMIDINIC SITE) LYASE; DNA DIRECTED DNA POLYMERASE GAMMA; DNA GLYCOSYLTRANSFERASE; DOUBLE STRANDED DNA; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL DNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; REACTIVE OXYGEN METABOLITE;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; B LYMPHOCYTE; CAENORHABDITIS ELEGANS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; DNA REPAIR; DNA STRAND BREAKAGE; DROSOPHILA MELANOGASTER; ELECTRON TRANSPORT; ENZYME ACTIVITY; EXCISION REPAIR; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LIFESPAN; MAMMAL CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SOMATIC CELL; T LYMPHOCYTE;

EID: 0037202593     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(02)00221-X     Document Type: Article

References (119)

1. Taylor A.M.R., Harnden D.G., Arlett C.F., Harcourt S.A., Lehmann A.R., Stevens S., Bridges B.A. Ataxia-telangiectasia, a human mutation with abnormal radiation sensitivity. Nature. 258:1975;427-429.
2. Bridges B.A. Some DNA-repair-deficient human syndromes and their implications for human health. Proc. R. Soc. B. 212:1981;263-278.
3. Taccioli G.E., Rathbun G., Oltz E., Stamato T., Jeggo P.A., Alt F.W. Impairment of V(D)J recombination in double strand break repair mutants. Science. 260:1993;207-210.
4. Taccioli G.E., Gottlieb T.M., Blunt T., Priestley A., Demengeot J., Mizuta R., Lehmann A.R., Alt F.W., Jackson S.P., Jeggo P.A. Ku80: product of the XRCC5 gene. Role in DNA repair and V(D)J recombination. Science. 265:1994;1442-1445.
5. P.A. Jeggo, DNA breakage and repair, in: J.C. Hall, J.C. Dunlap, T. Friedmann, F. Giannelli (Eds.), Advances in Genetics, Academic Press, San Diego, 1998, pp. 185-211.
6. Caspari T., Davies C., Carr A.M. Analysis of the fission yeast checkpoint rad proteins. Cold Spring Harbor Symp. Quant. Biol. 65:2000;451-456.
7. Lavin M.F., Khanna K.K. ATM: the protein encoded by the gene mutated in the radiosensitive syndrome ataxia-telangiectasia. Int. J. Radiat. Biol. 75:1999;1201-1214.
8. Shiloh Y. ATM and ATR: networking cellular responses to DNA damage. Curr. Opin. Genet. Dev. 11:2001;71-77.
9. Rotman G., Shiloh Y. The ATM gene and protein: possible roles in genome surviellance. Cancer Surv. 29:1997;285-304.
10. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D.A., Smith S., Uziel T., Sfez S., Ashkenazi M., Pecker I., Frydman M., Harnik R., Patanjali S.R., Simmons A., Clines G.A., Sartiel A., Gatti R.A., Chessa L., Sanal O., Lavin M.F., Jaspers N.G.J., Taylor M.R., Arlett C.F., Miki T., Weissman S.M., Lovett M., Collins F.S., Shiloh Y. A single Ataxia-telangiectasia gene with a product similar to PI 3-kinase. Science. 268:1995;1749-1753.
11. Banin S., Moyal L., Shieh S., Taya Y., Anderson C.W., Chessa L., Smorodinsky N.I., Prives C., Reiss Y., Shiloh Y., Ziv Y. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 281:1998;1674-1677.
12. Canman C.E., Lim D.S., Cimprich K.A., Taya Y., Tamai K., Sakaguchi K., Appella E., Kastan M.B., Siliciano J.D. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science. 281:1998;1677-1679.
13. Smith G.C., Cary R.B., Larkin N.D., Hann B.C., Teo S.H., Chen D.J., Jackson S.P. Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM. Proc. Natl. Acad. Sci. U.S.A. 96:1999;11134-11139.
14. Thacker J. Cellular radiosensitivity in ataxia-telangiectasia. Int. J. Radiat. Biol. 66:1994;S87-S96.
15. Jeggo P.A., Carr A.M., Lehmann A.R. Splitting the ATM: distinct repair and checkpoint defects in ataxia-telangiectasia. Trends Genet. 14:1998;312-316.
16. Girard P.-M., Riballo E., Begg A., Waugh A., Jeggo P.A. Nbs1 promotes ATM dependent phosphorylation events including those required for G1/S arrest. Oncogene. 21:2002;4191-4199.
17. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double strand breaks. J. Biol. Chem. 276:2001;42462-42467.
18. Paull T.T., Rogakou E.P., Yamazaki V., Kirchgessner C.U., Gellert M., Bonner W.M. A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage. Curr. Biol. 10:2000;886-895.
19. Celeste A., Petersen S., Romanienko P.J., Fernandez-Capetillo O., Chen H.T., Sedelnikova O.A., Reina-San-Martin B., Coppola V., Meffre E., Difilippantonio M.J., Redon C., Pilch D.R., Olaru A., Eckhaus M., Camerini-Otero R.D., Tessarollo L., Livak F., Manova K., Bonner W.M., Nussenzweig M.C., Nussenzweig A. Genomic instability in mice lacking histone H2AX. Science. 4:2002;4.
20. Tibbetts R.S., Brumbaugh K.M., Williams J.M., Sarkaria J.N., Cliby W.A., Shieh S.Y., Taya Y., Prives C., Abraham R.T. A role for ATR in the DNA damage-induced phosphorylation of p53. Genes Dev. 13:1999;153-157.
21. Kanaar R., Hoeijmakers J.H., van Gent D.C. Molecular mechanisms of DNA double strand break repair. Trends Cell Biol. 8:1998;483-489.
22. Sonoda E., Takata M., Yamashita Y.M., Morrison C., Takeda S. Homologous DNA recombination in vertebrate cells. Proc. Natl. Acad. Sci. U.S.A. 98:2001;8388-8394.
23. Thompson L.H., Schild D. Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat. Res. 477:2001;131-153.
24. Thacker J. The role of homologous recombination processes in the repair of severe forms of DNA damage in mammalian cells. Biochimie. 81:1999;77-85.
25. Streisinger G., Owen J. Mechanisms of spontaneous and induced frameshift mutations in bacteriophage T4. Genetics. 109:1985;633-659.
26. Buermeyer A.B., Deschenes S.M., Baker S.M., Liskay R.M. Mammalian DNA mismatch repair. Annu. Rev. Genet. 33:1999;533-564.
27. Palombo F., Iaccarino I., Nakajima E., Ikejima M., Shimada T., Jiricny J. hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA. Curr. Biol. 6:1996;1181-1184.
28. Genschel J., Littman S.J., Drummond J.T., Modrich P. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. J. Biol. Chem. 273:1998;19895-198901.
29. Li G.M., Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc. Natl. Acad. Sci. U.S.A. 92:1995;1950-1954.
30. Leung W.K., Kim J.J., Wu L., Sepulveda J.L., Sepulveda A.R. Identification of a second MutL DNA mismatch repair complex (hPMS1 and hMLH1) in human epithelial cells. J. Biol. Chem. 275:2000;15728-15732.
31. Raschle M., Marra G., Nystrom-Lahti M., Schar P., Jiricny J. Identification of hMutLbeta, a heterodimer of hMLH1 and hPMS1. J. Biol. Chem. 274:1999;32368-32375.
32. Schmutte C., Marinescu R.C., Sadoff M.M., Guerrette S., Overhauser J., Fishel R. Human exonuclease I interacts with the mismatch repair protein hMSH2. Cancer Res. 58:1998;4537-4542.
33. Tishkoff D.X., Amin N.S., Viars C.S., Arden K.C., Kolodner R.D. Identification of a human gene encoding a homologue of Saccharomyces cerevisiae EXO1, an exonuclease implicated in mismatch repair and recombination. Cancer Res. 58:1998;5027-5031.
34. Bennett S.E., Umar A., Oshima J., Monnat R.J. Jr., Kunkel T.A. Mismatch repair in extracts of Werner syndrome cell lines. Cancer Res. 57:1997;2956-2960.
35. Longley M.J., Pierce A.J., Modrich P. DNA polymerase delta is required for human mismatch repair in vitro. J. Biol. Chem. 272:1997;10917-10921.
36. Lin Y.L., Shivji M.K., Chen C., Kolodner R., Wood R.D., Dutta A. The evolutionarily conserved zinc finger motif in the largest subunit of human replication protein A is required for DNA replication and mismatch repair but not for nucleotide excision repair. J. Biol. Chem. 273:1998;1453-1461.
37. Umar A., Buermeyer A.B., Simon J.A., Thomas D.C., Clark A.B., Liskay R.M., Kunkel T.A. Requirement for PCNA in DNA mismatch repair at a step preceding DNA resynthesis. Cell. 87:1996;65-73.
38. Gellert M. Recent advances in understanding V(D)J recombination. Adv. Immunol. 64:1997;39-64.
39. Willerford D.M., Swat W., Alt F.W. Developmental regulation of V(D)J recombination and lymphocyte differentiation. Curr. Opin. Genet. Dev. 6:1996;603-609.
40. Lewis S.M. Evolution of immunoglobulin and T-cell receptor gene assembly. Ann. N. Y. Acad. Sci. 870:1999;58-67.
41. Fugmann S.D., Lee A.I., Shockett P.E., Villey I.J., Schatz D.G. The RAG proteins and V(D)J recombination: complexes, ends, and transposition. Annu. Rev. Immunol. 18:2000;495-527.
42. Hesslein D.G., Schatz D.G. Factors and forces controlling V(D)J recombination. Adv. Immunol. 78:2001;169-232.
43. Moshous D., Callebaut I., de Chasseval R., Corneo B., Cavazzana-Calvo M., Le Deist F., Tezcan I., Sanal O., Bertrand Y., Philippe N., Fischer A., de Villartay J.P. Artemis, a novel DNA double strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency. Cell. 105:2001;177-186.
44. Ma Y., Pannicke U., Schwarz K., Lieber M.R. Hairpin opening and overhang processing by an artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell. 108:2002;781-794.
45. Lewis S.M. P nucleotide insertions and the resolution of hairpin DNA structures in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 91:1994;1332-1336.
46. Pergola F., Zdzienicka M.Z., Lieber M.R. V(D)J recombination in mammalian cell mutants defective in DNA double strand break repair. Mol. Cell. Biol. 13:1993;3464-3471.
47. Bosma G.C., Custer R.P., Bosma M.J. A severe combined immunodeficiency mutation in the mouse. Nature. 301:1983;527-530.
48. Bosma G.C., Davisson M.T., Ruetsch N.R., Sweet H.O., Shultz L.D., Bosma M.J. The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. Immunogenetics. 29:1989;54-57.
49. Blunt T., Gell D., Fox M., Taccioli G.E., Jackson S.P., Lehmann A.R., Jeggo P.A. Identification of a nonsense mutation in the carboxy-terminal region of DNA-dependent protein kinase catalytic subunit in the scid mouse. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10285-10290.
50. Araki R., Fujimori A., Hamatani K., Mita K., Saito T., Mori M., Fukumura R., Morimyo M., Muto M., Itoh M., Tatsumi K., Abe M. Nonsense mutation at Tyr-4046 in the DNA-dependent protein kinase catalytic subunit of severe combined immune deficiency mice. Proc. Natl. Acad. Sci. U.S.A. 94:1997;2438-2443.
51. Taccioli G.E., Amatucci A.G., Beamish H.J., Gell D., Torres Arzayus M.I., Priestley A., Jackson S.P., Rothstein A.M., Jeggo P.A., Herrera V.L.M., Xiang X.H. Targeted disruption of the catalytic subunit of the DNA-PK gene in mice confers severe combined immunodeficiency and radiosensitivity. Immunity. 9:1998;355-366.
52. Gao Y., Chaudhuri J., Zhu C., Davidson L., Weaver D.T., Alt F.W. A targeted DNA-PKcs-null mutation reveals DNA-PK-independent functions for Ku in V(D)J recombination. Immunity. 9:1998;367-376.
53. Nussenzweig A., Chen C., da Costa Soares V., Sanchez M., Sokol K., Nussenzweig M.C., Li G.C. Requirement for Ku80 in growth and immunoglobulin V(D)J recombination. Nature. 382:1996;551-555.
54. Zhu C.M., Bogue M.A., Lim D.S., Hasty P., Roth D.B. Ku86-deficient mice exhibit severe combined immunodeficiency and defective processing of V(D)J recombination intermediates. Cell. 86:1996;379-389.
55. Frank K.M., Sharpless N.E., Gao Y., Sekiguchi J.M., Ferguson D.O., Zhu C., Manis J.P., Horner J., DePinho R.A., Alt F.W. DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol. Cell. 5:2000;993-1002.
56. Barnes D.E., Stamp G., Rosewell I., Denzel A., Lindahl T. Targeted disruption of the gene encoding DNA ligase IV leads to lethality in embryonic mice. Curr. Biol. 8:1998;1395-1398.
57. Grawunder U., Zimmer D., Fugmann S., Schwarz K., Lieber M.R. DNA ligase IV is essential for V(D)J recombination and DNA double strand break repair in human precursor lymphocytes. Mol. Cell. 2:1998;477-484.
58. Honjo T., Kinoshita K., Muramatsu M. Molecular mechanism of class switch recombination: linkage with somatic hypermutation. Annu. Rev. Immunol. 20:2002;165-196.
59. Manis J.P., Tian M., Alt F.W. Mechanism and control of class-switch recombination. Trends Immunol. 23:2002;31-39.
60. Kinoshita K., Lee C.G., Tashiro J., Muramatsu M., Chen X.C., Yoshikawa K., Honjo T. Molecular mechanism of immunoglobulin class switch recombination. Cold Spring Harb. Symp. Quant. Biol. 64:1999;217-226.
61. Kinoshita K., Honjo T. Unique and unprecedented recombination mechanisms in class switching. Curr. Opin. Immunol. 12:2000;195-198.
62. Stavnezer J. Molecular processes that regulate class switching. Curr. Top Microbiol. Immunol. 245:2000;127-168.
63. Muramatsu M., Kinoshita K., Fagarasan S., Yamada S., Shinkai Y., Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell. 102:2000;553-563.
64. Rolink A., Melchers F., Andersson J. The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching. Immunity. 5:1996;319-330.
65. Casellas R., Nussenzweig A., Wuerffel R., Pelanda R., Reichlin A., Suh H., Qin X.F., Besmer E., Kenter A., Rajewsky K., Nussenzweig M.C. Ku80 is required for immunoglobulin isotype switching. EMBO J. 17:1998;2404-2411.
66. Manis J.P., Gu Y., Lansford R., Sonoda E., Ferrini R., Davidson L., Rajewsky K., Alt F.W. Ku70 is required for late B cell development and immunoglobulin heavy chain class switching. J. Exp. Med. 187:1998;2081-2089.
67. Petersen S., Casellas R., Reina-San-Martin B., Chen H.T., Difilippantonio M.J., Wilson P.C., Hanitsch L., Celeste A., Muramatsu M., Pilch D.R., Redon C., Ried T., Bonner W.M., Honjo T., Nussenzweig M.C., Nussenzweig A. AID is required to initiate Nbs1/gamma-H2AX focus formation and mutations at sites of class switching. Nature. 414:2001;660-665.
68. Ehrenstein M.R., Neuberger M.S. Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation. EMBO J. 18:1999;3484-3490.
69. Schrader C.E., Vardo J., Stavnezer J. Role for mismatch repair proteins msh2, mlh1, and pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions. J. Exp. Med. 195:2002;367-373.
70. Ehrenstein M.R., Rada C., Jones A.M., Milstein C., Neuberger M.S. Switch junction sequences in PMS2-deficient mice reveal a microhomology-mediated mechanism of Ig class switch recombination. Proc. Natl. Acad. Sci. U.S.A. 98:2001;14553-14558.
71. Diaz M., Casali P. Somatic immunoglobulin hypermutation. Curr. Opin. Immunol. 14:2002;235-240.
72. Wedemayer G.J., Patten P.A., Wang L.H., Schultz P.G., Stevens R.C. Structural insights into the evolution of an antibody combining site. Science. 276:1997;1665-1669.
73. Fukita Y., Jacobs H., Rajewsky K. Somatic hypermutation in the heavy chain locus correlates with transcription. Immunity. 9:1998;105-114.
74. Storb U., Peters A., Kim N., Shen H.M., Bozek G., Michael N., Hackett J. Jr., Klotz E., Reynolds J.D., Loeb L.A., Martin T.E. Molecular aspects of somatic hypermutation of immunoglobulin genes. Cold Spring Harb. Symp. Quant. Biol. 64:1999;227-234.
75. Papavasiliou F.N., Schatz D.G. Cell-cycle-regulated DNA double stranded breaks in somatic hypermutation of immunoglobulin genes. Nature. 408:2000;216-221.
76. Bemark M., Sale J.E., Kim H.J., Berek C., Cosgrove R.A., Neuberger M.S. Somatic hypermutation in the absence of DNA-dependent protein kinase catalytic subunit (DNA-PK(cs)) or recombination-activating gene (RAG1) activity. J. Exp. Med. 192:2000;1509-1514.
77. Wood R.D. DNA repair: knockouts still mutating after first round. Curr. Biol. 8:1998;R757-760.
78. Winter D.B., Gearhart P.J. Altered spectra of hypermutation in DNA repair-deficient mice. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356:2001;5-11.
79. Rada C., Ehrenstein M.R., Neuberger M.S., Milstein C. Hot spot focusing of somatic hypermutation in MSH2-deficient mice suggests two stages of mutational targeting. Immunity. 9:1998;135-141.
80. Frey S., Bertocci B., Delbos F., Quint L., Weill J.C., Reynaud C.A. Mismatch repair deficiency interferes with the accumulation of mutations in chronically stimulated B cells and not with the hypermutation process. Immunity. 9:1998;127-134.
81. Sale J.E., Calandrini D.M., Takata M., Takeda S., Neuberger M.S. Ablation of XRCC2/3 transforms immunoglobulin V gene conversion into somatic hypermutation. Nature. 412:2001;921-926.
82. Taylor A.M.R., Metcalfe J.A., Thick J., Mak Y.F. Leukemia and lymphoma in Ataxia-telangiectasia. Blood. 87:1996;423-438.
83. Shiloh Y. Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. Annu. Rev. Genet. 31:1997;635-662.
84. Hsieh C.-L., Arlett C.F., Lieber M.R. V(D)J recombination in Ataxia-telangiectasia, Bloom's Syndrome, and a DNA ligase I-associated immunodeficiency disorder. J. Biol. Chem. 268:1993;20105-20109.
85. Allen D.M., van Praag H., Ray J., Weaver Z., Winrow C.J., Carter T.A., Braquet R., Harrington E., Ried T., Brown K.D., Gage F.H., Barlow C. Ataxia-telangiectasia mutated is essential during adult neurogenesis. Genes Dev. 15:2001;554-566.
86. Kastan M.B., Zhan Q., El-Deiry W.S., Carrier F., Jacks T., Walsh W.V., Plunkett B.S., Vogelstein B., Fornace A.J. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 71:1992;587-597.
87. Stewart G.S., Maser R.S., Stankovic T., Bressan D.A., Kaplan M.I., Jaspers N.G., Raams A., Byrd P.J., Petrini J.H., Taylor A.M. The DNA double strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder. Cell. 99:1999;577-587.
88. Xiao Y., Weaver D.T. Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double strand break repair Mre11 protein in murine embryonic stem cells. Nucleic Acids Res. 25:1997;2985-2991.
89. Carney J.P., Maser R.S., Olivares H., Davis E.M., Le Beau M., Yates J.R. Jr., Hays L., Morgan W.F., Petrini J.H.J. The hMre11/hRad50 protein complex and Nijmegen breakage-syndrome: linkage of double strand break repair to the cellular DNA damage response. Cell. 93:1998;477-486.
90. Varon R., Vissinga C., Platzer M., Cerosaletti K.M., Chrzanowska K.H., Saar K., Beckmann G., Seemanova E., Cooper P.R., Nowak N.J., Stumm M., Weemaes C.M.R., Gatti R.A., Wilson R.K., Digweed M., Rosenthal A., Sperling K., Concannon P., Reis A. Nibrin, a novel DNA double strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 93:1998;467-476.
91. Maser R.S., Zinkel R., Petrini J.H. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat. Genet. 27:2001;417-421.
92. Zhu J., Petersen S., Tessarollo L., Nussenzweig A. Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice. Curr. Biol. 11:2001;105-109.
93. International Nijmegen Breakage Syndrome Study Group, Nijmegen breakage syndrome. Arch. Dis. Child 82 (2000) 400-406.
94. R.D. Wegner, K. Chrzanowska, K. Sperling, M. Stumm, Ataxia-telangiectasia variants (Nijmegen breakage syndrome), in: H.D. Ochs, J.M. Puck, C.I.E. Smith (Eds.), Primary Immunodeficincy Diseases, A Molecular and Genetic Approach, Oxford University Press, New York, 1999, pp. 324-334.
95. Yeo T.C., Dong X., Sabath D.E., Sperling K., Gatti R.A., Concannon P., Willerford D.M. V(D)J rearrangement in Nijmegen breakage syndrome. Mol. Immunol. 37:2000;1131-1139.
96. Riballo E., Critchlow S.E., Teo S.H., Doherty A.J., Priestley A., Broughton B., Kysela B., Beamish H., Plowman N., Arlett C.F., Lehmann A.R., Jackson S.P., Jeggo P.A. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr. Biol. 19:1999;699-702.
97. O'Driscoll M., Cerosaletti K.M., Girard P.-M., Dai Y., Stumm M., Kysela B., Hirsch B., Gennery A., Palmer S.E., Seidel J., Gatti R.A., Varon R., Oettinger M.A., Sperling K., Jeggo P.A., Concannon P. DNA Ligase IV mutations identified in patients exhibiting development delay and immunodeficiency. Mol. Cell. 8:2001;1175-1185.
98. Moshous D., Li L., Chasseval R., Philippe N., Jabado N., Cowan M.J., Fischer A., Villartay J.P. A new gene involved in DNA double strand break repair and V(D)J recombination is located on human chromosome 10p. Hum. Mol. Genet. 9:2000;583-588.
99. Nicolas N., Moshous D., Cavazzana-Calvo M., Papadopoulo D., de Chasseval R., Le Deist F., Fischer A., de Villartay J.P. A human severe combined immunodeficiency (SCID) condition with increased sensitivity to ionizing radiations and impaired V(D)J rearrangements defines a new DNA recombination/repair deficiency. J. Exp. Med. 188:1998;627-634.
100. Villa A., Santagata S., Bozzi F., Giliani S., Frattini A., Imberti L., Gatta L.B., Ochs H.D., Schwarz K., Notarangelo L.D., Vezzoni P., Spanopoulou E. Partial V(D)J recombination activity leads to Omenn syndrome. Cell. 93:1998;885-896.
101. Sproston A.R.M., West C.M.L., Hendry J.H. Cellular radiosensitivity in human severe-combined-immunodeficiency (SCID) syndromes. Radiother. Oncol. 42:1997;53-57.
102. Cavazzana Calvo M., Le Deist F., De Saint Basile G., Papadopoulo D., De Villartay J.P., Fischer A. Increased radiosensitivity of granulocyte macrophage colony-forming units and skin fibroblasts in human autosomal recessive severe combined immunodeficiency. J. Clin. Invest. 91:1993;1214-1218.
103. Barnes D.E., Tomkinson A.E., Lehmann A.R., Webster A.D.B., Lindahl T. Mutations in the DNA ligase 1 gene of an individual with immunodeficiencies and cellular hypersensitivity to DNA damaging agents. Cell. 69:1992;495-503.
104. Henderson L.M., Arlett C.F., Harcourt S.A., Lehmann A.R., Broughton B.C. Cells from an immunodeficient patient (46BR) with a defect in DNA ligation are hypomutable but hypersensitive to the induction of sister chromatid exchanges. Proc. Natl. Acad. Sci. U.S.A. 82:1985;2044-2048.
105. Lehmann A.R., Willis A.E., Broughton B.C., Steingrimsdottir H., Harcourt S.A., Arlett C.F., Lindahl T. Relation between the human fibroblast strain 46BR and cell lines representative of Bloom's syndrome. Cancer Res. 48:1988;6343-6347.
106. Webster A.D.B., Barnes D.E., Arlett C.F., Lehmann A.R., Lindahl T. Growth retardation and immunodeficiency in a patient with mutations in the DNA ligase I gene. Lancet. 339:1992;1508-1509.
107. Garssen J., van Steeg H., de Gruijl F., de Boer J., van der Horst G.T., van Kranen H., van Loveren H., van Dijk M., Fluitman A., Weeda G., Hoeijmakers J.H. Transcription-coupled and global genome repair differentially influence UV-B-induced acute skin effects and systemic immunosuppression. J. Immunol. 164:2000;6199-6205.
108. Kripke M.L. Immunologic mechanisims in UV radiation carcinogenesis. Adv. Cancer Res. 34:1981;69-106.
109. Norris P.G., Lehmann A.R., Cole J., Arlett C.F., Hawk J.L.M. Photosensitivity and lymphocyte hypermutability in Cockayne's syndrome. Br. J. Dermatol. 124:1991;453-460.
110. Norris P.G., Limb G.A., Hamblin A.S., Lehmann A.R., Arlett C.F., Cole J., Waugh A.P.W., Hawk J.L.M. Immune function, mutant frequency and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome and trichothiodystrophy. J. Invest. Dermatol. 94:1990;94-100.
111. Howlett N.G., Taniguchi T., Olson S., Cox B., Waisfisz Q., De Die-Smulders C., Persky N., Grompe M., Joenje H., Pals G., Ikeda H., Fox E.A., D'Andrea A.D. Biallelic inactivation of BRCA2 in Fanconi anemia. Science. 297:2002;606-609.
112. Smith J., Andrau J.C., Kallenbach S., Laquerbe A., Doyen N., Papadopoulo D. Abnormal rearrangements associated with V(D)J recombination in Fanconi anemia. J. Mol. Biol. 281:1998;815-825.
113. Mohaghegh P., Hickson I.D. DNA helicase deficiencies associated with cancer predisposition and premature aging disorders. Hum. Mol. Genet. 10:2001;741-746.
114. Mitchell J.R., Wood E., Collins K. A telomerase component is defective in the human disease dyskeratosis congenita. Nature. 402:1999;551-555.
115. Vulliamy T., Marrone A., Goldman F., Dearlove A., Bessler M., Mason P.J., Dokal I. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 413:2001;432-435.
116. Herrera E., Martinez A.C., Blasco M.A. Impaired germinal center reaction in mice with short telomeres. EMBO J. 19:2000;472-481.
117. Dokal I., Bungey J., Williamson P., Oscier D., Hows J., Luzzatto L. Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements. Blood. 80:1992;3090-3096.
118. McIlrath J., Bouffler S.D., Samper E., Cuthbert A., Wojcik A., Szumiel I., Bryant P.E., Riches A.C., Thompson A., Blasco M.A., Newbold R.F., Slijepcevic P. Telomere length abnormalities in mammalian radiosensitive cells. Cancer Res. 61:2001;912-915.
119. Wong K.K., Chang S., Weiler S.R., Ganesan S., Chaudhuri J., Zhu C., Artandi S.E., Rudolph K.L., Gottlieb G.J., Chin L., Alt F.W., DePinho R.A. Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation. Nat. Genet. 26:2000;85-88.